CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Its downregulation in all CD34+ fractions of CML patients along with the demonstration that its forced up- and downregulation in CML cells reduces and increases, respectively, clonogenic capacity [8], suggesting a key role in the maintenance of the disease.